IP Library › Granted Patent US 12,303,182
Granted Patent B2
US 12,303,182 · App. 18/340,610 · Granted May 20, 2025

Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode

Inventor: Robert E. Neal, II (Blacksburg, VA)
Assignee: AngioDynamics, Inc.
A61B18/12A61B18/1477A61N1/0412A61B2018/00452A61B2018/00577A61B2018/00613A61B2018/00791A61B2018/00875A61B2018/00964A61B2018/143A61B2018/1432A61B2018/1475A61N1/327
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,303,182
App. No.
18/340,610
Granted
May 20, 2025
Kind
B2
Abstract

Techniques for High-Frequency Irreversible Electroporation (HFIRE) using a single-pole tine-style internal device communicating with an external surface electrode are described. In an embodiment, a system for ablating tissue cells in a treatment region of a patient's body by irreversible electroporation without thermally damaging the tissue cells is described. The system includes at least one single-pole electrode probe for insertion into the treatment region, the single-pole electrode probe including one or more tines. The system further includes at least one external surface electrode for placement outside the patient's body and configured to complete a circuit with the single-pole electrode probe. The system also includes a control device for controlling HFIRE pulses to the single-pole tine-style electrode and the skin-surface electrode for the delivery of electric energy to the treatment region. Other embodiments are described and claimed.

Claims (44)

1. A method for ablating cells in a treatment site of a patient, the method comprising:

advancing a monopolar electrode through a shaft positioned within the treatment site such that the monopolar electrode does not extend distally of a distal end of the shaft, wherein the distal end of the shaft is conductive;

placing a surface electrode on a surface of the patient;

activating a generator to apply a first set of electrical pulses between the conductive distal end of the shaft and the surface electrode in an amount sufficient to induce non-thermal ablation of the treatment site by high-frequency irreversible electroporation (HFIRE), wherein the first set of pulses include bi-phasic pulses having a delay between adjacent pulses and wherein the first set of electrical pulses have a voltage of between about 2,500 V and about 10,000 V, thereby enabling treatment while mitigating muscle contractions without the administration of a paralytic to the treatment site;

wherein the first set of electrical pulses are configured to create a first ablation zone and a first electrical pull zone such that a size of the first ablation zone is increased in the first electrical pull zone,

wherein the distal end of the shaft includes a sharp distal tip and the shaft includes an insulation sleeve portion that is positioned proximally of the sharp distal tip, and

wherein the sharp distal tip comprises about 1 cm of exposure from the insulation sleeve portion.

2. The method of claim 1 , wherein the treatment site includes an organ, and the shaft is positioned relative to the organ.

3. The method of claim 2 , wherein the organ is a liver, kidney or lung.

4. The method of claim 2 , wherein the monopolar electrode includes one or more deployable tines configured to deploy from the shaft proximal of the sharp distal tip, and wherein the method further comprises:

deploying the deployable tines.

5. The method of claim 4 , wherein the one or more deployable tines are arranged in multiple tiers around the shaft.

6. The method of claim 1 , wherein the monopolar electrode does not extend through the sharp distal tip.

7. The method of claim 1 , further comprising:

moving the surface electrode to a second location on the surface of the patient; and

activating the generator to apply a second set of electrical pulses between the conductive distal end of the shaft and the surface electrode while the surface electrode is in the second location.

8. The method of claim 7 , wherein the second set of electrical pulses is configured to induce a second electrical pull zone.

9. The method of claim 1 , wherein the first set of electrical pulses comprise a pulse width of between about 100 nanoseconds and about 10 microseconds;

wherein the first set of electrical pulses delivered in burst widths of between about 500 nanoseconds and about 1 millisecond; and

wherein a time delay between bursts is between about 1 millisecond and about 5 seconds.

10. A method for ablating cells in a treatment site of a patient, the method comprising:

advancing a monopolar electrode through a shaft positioned within the treatment site, wherein the shaft includes a sharp distal tip that is electrically conductive and the monopolar electrode does not advance through the sharp distal tip;

placing a surface electrode on a surface of the patient; and

activating a generator to apply a first set of electrical pulses between the conductive distal tip of the shaft and the surface electrode in an amount sufficient to induce non-thermal ablation of the treatment site by high-frequency irreversible electroporation (HFIRE);

wherein the first set of electrical pulses are configured to create a first ablation zone and a first electrical pull zone such that a size of the first ablation zone is increased in the first electrical pull zone; and

wherein the first set of pulses are applied according to parameters that mitigate muscle contractions and obviate a need to deliver a paralytic, wherein the parameters comprise: a bi-phasic waveform, a pulse width of between about 100 nanoseconds and about 10 microseconds, a delay between adjacent pulses, a voltage of between about 2,500 V and about 10,000 V, burst widths of between about 500 nanoseconds and about 1 millisecond, and a time delay between bursts of between about 1 millisecond and about 5 seconds.

11. The method of claim 10 , wherein the shaft includes an insulation sleeve portion that is proximal of the sharp distal tip.

12. The method of claim 11 , wherein the sharp distal tip comprises about 1 cm of exposure from the insulation sleeve portion.

13. The method of claim 12 , wherein the 1 cm of exposure of the sharp distal tip is an active distal tip.

14. The method of claim 10 , wherein the monopolar electrode includes one or more deployable tines configured to deploy from the shaft proximally of the sharp distal tip, and wherein the method further comprises:

deploying the deployable tines.

15. The method of claim 14 , wherein the one or more deployable tines are arranged in multiple tiers around the shaft.

16. The method of claim 15 , further comprising:

moving the surface electrode to a second location on the surface of the patient; and

activating the generator to apply a second set of electrical pulses between the conductive distal tip of the shaft and the surface electrode while the surface electrode is in the second location.

17. The method of claim 16 , wherein the second set of electrical pulses is configured to induce a second electrical pull zone.

18. The method of claim 17 , wherein the second electrical pull zone increases the size of the initial ablation zone by up to 3 millimeters.

19. The method of claim 10 , wherein the ablation zone comprises an ablation volume that is spherical in shape.

20. A method for ablating cells in a treatment site of a patient, the method comprising:

advancing a monopolar electrode through a shaft positioned within the treatment site, wherein the shaft includes a sharp distal tip that is electrically conductive and the shaft includes an insulation sleeve portion that is proximal of the sharp distal tip, wherein the sharp distal tip includes about 1 cm of exposure from the insulation sleeve portion, and wherein the monopolar electrode does not advance through the sharp distal tip;

placing a surface electrode on a surface of the patient; and

activating a generator to apply a first set of electrical pulses between the conductive distal tip of the shaft and the surface electrode in an amount sufficient to induce non-thermal ablation of the treatment site by high-frequency irreversible electroporation (HFIRE);

wherein the first set of electrical pulses are configured to create a first spherical ablation zone and a first electrical pull zone such that a size of the first spherical ablation zone is increased in the first electrical pull zone; and

wherein the first set of pulses are applied according to parameters that mitigate muscle contractions and obviate a need to deliver a paralytic, wherein the parameters comprise: a bi-phasic waveform, a pulse width of between about 100 nanoseconds and about 10 microseconds, a delay between adjacent pulses, a voltage of between about 2,500 V and about 10,000 V, burst widths of between about 500 nanoseconds and about 1 millisecond, and a time delay between bursts of between about 1 millisecond and about 5 seconds.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2023
From: NEAL, ROBERT E., II
To: ANGIODYNAMICS, INC.
Reel/Frame 064125/0081 →
Continuity (4)
Continuation 17147131 · Jan 12, 2021
Continuation 15685355 · Aug 24, 2017
Provisional Application 62423256 · Nov 17, 2016
Related Publication 20240016535A1 · Jan 18, 2024
References Cited (109)
US 5749914A · Janssen · 1998 [cited by applicant]
US 5759158A · Swanson · 1998 [cited by applicant]
US 6009647A · Feingold · 2000 [cited by applicant]
US 6010616A · Lewis · 2000 [cited by applicant]
US 6033402A · Tu · 2000 [cited by applicant]
US 6055456A · Gerber · 2000 [cited by applicant]
US 6135999A · Fanton · 2000 [cited by applicant]
US 7871406B2 · Nields · 2011 [cited by applicant]
US 8055323B2 · Sawyer · 2011 [cited by applicant]
US 9700368B2 · Callas · 2017 [cited by applicant]
US 10905492B2 · Neal, II · 2021 [cited by examiner]
US 11638603B2 · Sano · 2023 [cited by applicant]
US 11655466B2 · Neal, II · 2023 [cited by applicant]
US 11723710B2 · Neal, II · 2023 [cited by examiner]
US 11737810B2 · Davalos · 2023 [cited by applicant]
US 11890046B2 · Neal · 2024 [cited by applicant]
US 11903690B2 · Davalos · 2024 [cited by applicant]
US 11925405B2 · Davalos · 2024 [cited by applicant]
US 11950835B2 · O'Brien · 2024 [cited by applicant]
US 11952568B2 · Neal, II · 2024 [cited by applicant]
US 11974800B2 · Sano · 2024 [cited by applicant]
US 12059197B2 · Davalos · 2024 [cited by applicant]
US 20010043706A1 · Masuda · 2001 [cited by applicant]
US 20040116935A1 · Lechot · 2004 [cited by applicant]
US 20040237340A1 · Rembrandt · 2004 [cited by applicant]
US 20050004567A1 · Daniel · 2005 [cited by applicant]
US 20050063974A1 · Reinhard · 2005 [cited by applicant]
US 20060234752A1 · Mese · 2006 [cited by applicant]
US 20070016125A1 · Wong · 2007 [cited by applicant]
US 20070129720A1 · Demarais · 2007 [cited by applicant]
US 20070153135A1 · Han · 2007 [cited by applicant]
US 20070203537A1 · Goetz · 2007 [cited by applicant]
US 20080009102A1 · Yang · 2008 [cited by applicant]
US 20080172104A1 · Kieval · 2008 [cited by applicant]
US 20080183256A1 · Keacher · 2008 [cited by applicant]
US 20080319511A1 · Pless · 2008 [cited by applicant]
US 20090326346A1 · Kracker · 2009 [cited by applicant]
US 20100030211A1 · Davalos · 2010 [cited by examiner]
US 20100160906A1 · Jarrard · 2010 [cited by applicant]
US 20100222377A1 · Crooks · 2010 [cited by applicant]
US 20100261994A1 · Davalos · 2010 [cited by examiner]
US 20110064371A1 · Leatherman · 2011 [cited by applicant]
US 20110190851A1 · Kelly · 2011 [cited by applicant]
US 20110238057A1 · Moss · 2011 [cited by examiner]
US 20120090643A1 · Bertsch · 2012 [cited by applicant]
US 20120136347A1 · Brustad · 2012 [cited by applicant]
US 20120220998A1 · Long · 2012 [cited by examiner]
US 20120265183A1 · Tulleken · 2012 [cited by applicant]
US 20130023871A1 · Collins · 2013 [cited by applicant]
US 20130030430A1 · Stewart · 2013 [cited by examiner]
US 20130033977A1 · Lin · 2013 [cited by applicant]
US 20130090346A1 · Johns · 2013 [cited by applicant]
US 20130110103A1 · Assmus · 2013 [cited by applicant]
US 20130296908A1 · Schulte · 2013 [cited by applicant]
US 20130338761A1 · Plowiecki · 2013 [cited by applicant]
US 20140276748A1 · Ku · 2014 [cited by applicant]
US 20150134584A1 · Nakagawa · 2015 [cited by applicant]
US 20160058493A1 · Neal, II · 2016 [cited by applicant]
US 20160143398A1 · Kim · 2016 [cited by applicant]
US 20160310203A1 · Gaspredes · 2016 [cited by applicant]
US 20160337310A1 · Faccin · 2016 [cited by applicant]
US 20170086713A1 · Pushpala · 2017 [cited by applicant]
US 20170360323A1 · Li · 2017 [cited by applicant]
US 20180028260A1 · Onik · 2018 [cited by applicant]
US 20180036529A1 · Jaroszeski · 2018 [cited by applicant]
US 20180132922A1 · Neal, II · 2018 [cited by applicant]
US 20180177543A1 · You · 2018 [cited by applicant]
US 20190023804A1 · Onik · 2019 [cited by applicant]
US 20190254736A1 · Wham · 2019 [cited by applicant]
US 20230157759A1 · Garcia · 2023 [cited by applicant]
US 20230212551A1 · Neal, II · 2023 [cited by applicant]
US 20230248414A1 · Sano · 2023 [cited by applicant]
US 20230355293A1 · Rafael · 2023 [cited by applicant]
US 20230355968A1 · Davalos · 2023 [cited by applicant]
US 20240008911A1 · Davalos · 2024 [cited by applicant]
US 20240074804A1 · Neal · 2024 [cited by applicant]
US 20240173063A1 · Neal, II · 2024 [cited by applicant]
US 20240268878A1 · Davalos · 2024 [cited by applicant]
US 20240277245A1 · Davalos · 2024 [cited by applicant]
US 20240299076A1 · O'Brien · 2024 [cited by applicant]
DE 833111 · 1952 [cited by applicant]
EP 0528891B1 · 2000 [cited by applicant]
EP 1061983B1 · 2004 [cited by applicant]
EP 0935482B1 · 2005 [cited by applicant]
EP 1406685B1 · 2008 [cited by applicant]
EP 1424970B1 · 2008 [cited by applicant]
JP 4252316A · 2009 [cited by applicant]
WO 2023172773A1 · 2023 [cited by applicant]
WO 2024081749A2 · 2024 [cited by applicant]
Alberts et al., “Molecular Biology of the Cell,” 3rd edition, Garland Science, New York, 1994, 1 page. [cited by applicant]
Bondarenko, A. and G. Ragoisha, Eis spectrum analyser (the program is available online at http://www.abc.chemistrybsu.by/vi/analyser/) (Accessed Aug. 28, 2020). [cited by applicant]
Latouche, E. L., M. B. Sano, M. F. Lorenzo, R. V. Davalos, and R. C. G. Martin, “Irreversible electroporation for the ablation of pancreatic malignancies: A patient-specific methodology,” J. Surg. Oncol., vol. 115, No. … [cited by applicant]
Lv, Y. et al. “The Englargement of Ablation Area by Electrolytic Irreversible Electroporation (E-IRE) Using Pulsed Field with Bias DC Field”, Annals of Biomedical Engineering, vol. 50, No. 12, Dec. 2022, 10 pages. [cited by applicant]
Mercadal, Borja et al. “Dynamics of Cell Death After Conventional IRE and H-Fire Treatments”, Annals of Biomedical Engineering, vol. 48, No. 5, 2020, p. 1451-1462. [cited by applicant]
Neal II et al., “A Case Report on the Successful Treatment of a Large Soft-Tissue Sarcoma with Irreversible Electroporation,” Journal of Clinical Oncology, 29, pp. 1-6, 2011. [cited by applicant]
PCT Application No. PCT/2011/062067, International Preliminary Report on Patentability dated May 28, 2013. 7 pages. [cited by applicant]
PCT Application No. PCT/2011/066239, International Preliminary Report on Patentability dated Jun. 25, 2013. 7 pages. [cited by applicant]
PCT Application No. PCT/US15/30429, International Report on Patentability dated Nov. 15, 2016. 7 pages. [cited by applicant]
PCT Application No. PCT/US19/51731 (VTIP-A1001-PCT), International Preliminary Report on Patentability dated Mar. 23, 2021, 13 pages. [cited by applicant]
PCT Application No. PCT/US2010/029243, International Search Report, 4 pgs, (Jul. 30, 2010), Written Opinion, 7 pgs, (Jul. 30, 2010), and International Preliminary Report on Patentability, 8 pgs, (Oct. 4, 2011). [cited by applicant]
Pending Application No. PCT/US21/51551 (VTIP-A1018-PCT), International Search Report and Written Opinion dated Dec. 29, 2021, 14 pages. [cited by applicant]
Pending Application No. PCT/US23/15118 (VTIP-A1023-PCT), International Search Report and Written Opinion dated Jul. 31, 2023, 18 pages. [cited by applicant]
Korohoda, W. et al. “Reversible and Irreversible Electroporation of Cell Suspensions Flowing Through a Localized DC Electric Field”, Cellular & Molecular Biology Letters, vol. 18 (2013), pp. 102-119 (published Dec. 27, … [cited by applicant]
Notice of Allowance dated Jun. 21, 2024 for U.S. Appl. No. 16/938,778 (pp. 1-10). [cited by applicant]
Notice of Allowance dated Jul. 24, 2024 for U.S. Appl. No. 16/938,778 (pp. 1-2). [cited by applicant]
Notice of Allowance dated Sep. 17, 2024 for U.S. Appl. No. 17/074,867 (pp. 1-8). [cited by applicant]
Pending Application No. PCT/US23/76626 (VTIP-A1024-PCT), International Search Report and Written Opinion, dated Apr. 28, 17, 2024, 12 pages. [cited by applicant]
Pending Application No. PCT/US23/76626 (VTIP-A1024-PCT), International Search Report and Written Opinion, dated Apr. 17, 2024, 12 pages. [cited by applicant]
Reti, I. M. and Davydow, D. S., “Electroconvulsive Therapy and Antibiotics: A Case Report”, J. ECT, vol. 23, No. 4, Dec. 29, 2007, pp. 289-290. [cited by applicant]